| MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE | None | ||
| 0.025MG;0.665MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| RYALTRIS is a combination of olopatadine, a histamine-1 (H1)receptor inhibitor, and mometasone furoate, a corticosteroid, indicated for the treatment of symptoms of seasonal allergic rhinitis in adult and pediatric patients 12 years of age and older. | |||
|
Yes
| |||
| RYALTRIS | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 | Patent 16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | ||||||||||||||||
| ****** ***** **** ************** *********** ********** ********** *** *********** | ****** ***** **** ************** *********** ********** ********** *** *********** | ****** ***** **** ************** *********** ********** ********** *** *********** | ****** ***** **** ************** *********** ********** ********** *** *********** | ********* ** ******** ******** ***** * *********** ** ********** *** *********** | ****** ***** **** ************** *********** ********** ********** *** *********** | ****** ***** **** ************** *********** ********** ********** *** *********** | ********* ** ******** ******** ***** * *********** ** ********** *** *********** | ****** ***** **** ************** *********** ********** ********** *** *********** | ********* ** ******** ******** ***** * *********** ** ********** *** *********** | ********* ** ******** ******** ***** * *********** ** ********** *** *********** | ****** ***** **** ************** *********** ********** ********** *** *********** | ********* ** ******** ******** ***** * *********** ** ********** *** *********** | ********** ****** *** ************** *********** *** *** ********* ** ******** | ********* ** ******** ******** ***** * *********** ** ********** *** *********** | ********** ****** *** ************** *********** *** *** ********* ** ******** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|